Published in J Virol on August 01, 1997
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res (2012) 2.14
High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol (2003) 2.04
Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J Virol (1997) 1.57
Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol (1999) 1.42
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol (2001) 1.06
Recombination between two identical sequences within the same retroviral RNA molecule. J Virol (1999) 1.03
Mechanisms and factors that influence high frequency retroviral recombination. Viruses (2011) 1.02
Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc Natl Acad Sci U S A (2002) 1.01
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication. J Virol (2000) 0.97
Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. J Virol (2000) 0.97
Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes. J Virol (2004) 0.94
Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer. J Virol (2005) 0.85
Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners. J Virol (2011) 0.83
Cross-packaging of genetically distinct mouse and primate retroviral RNAs. Retrovirology (2009) 0.82
Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression. J Virol (2000) 0.81
Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy. Mol Ther (2017) 0.80
Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription. J Virol (1999) 0.80
D-(+)-iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase. ChemMedChem (2008) 0.78
RRE-deleting self-inactivating and self-activating HIV-1 vectors for improved safety. PeerJ (2013) 0.75
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
A Fourth Generation Lentiviral Vector: Simplifying Genomic Gymnastics. Mol Ther (2017) 0.75
A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol Gen Genet (1979) 19.37
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
High mutation frequency in DNA transfected into mammalian cells. Proc Natl Acad Sci U S A (1983) 6.05
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J Virol (1985) 5.21
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Transfer of genes to humans: early lessons and obstacles to success. Science (1995) 3.64
Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions. J Virol (1991) 2.55
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A (1992) 2.09
An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol (1996) 1.38
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion. J Virol (1992) 1.32
Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J Virol (1994) 1.28
Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther (1991) 1.27
Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res (1994) 1.20
Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther (1994) 1.12
Improved self-inactivating retroviral vectors derived from spleen necrosis virus. J Virol (1994) 1.11
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther (1990) 1.09
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci U S A (1993) 1.06
Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther (1994) 1.03
Self-deleting retrovirus vectors for gene therapy. J Virol (1996) 1.01
Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther (1996) 0.94
Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes. Hum Gene Ther (1996) 0.91
Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993). Hum Gene Ther (1993) 0.91
Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line. Gene Ther (1996) 0.91
Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther (1992) 0.90
Retroviral vectors directed to predefined cell types for gene therapy. Biologicals (1995) 0.84
Retrovirus-mediated gene transfer in cancer therapy. Pharmacol Ther (1994) 0.82
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther (1995) 0.80
Metabolic suicide genes in gene therapy. Pharmacol Ther (1994) 0.80
Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines. Urol Res (1994) 0.80
A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer. Hum Gene Ther (1996) 0.78
HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937. Hum Gene Ther (1995) 0.78
Target and non-target effects of retrovirus vectors used for gene therapy and vaccination. Dev Biol Stand (1995) 0.78
Clinical applications of gene therapy for cancer. Clin Chem (1994) 0.78
Safety aspects of gene therapy. Br J Haematol (1992) 0.77
End-of-the-year potpourri--1996. Hum Gene Ther (1996) 0.77
The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol (1989) 4.81
Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J Virol (1997) 1.57
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg (1994) 1.46
Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc Natl Acad Sci U S A (2001) 1.44
Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate. J Virol (1998) 1.40
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol (1998) 1.34
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Multiple steady states with distinct cellular metabolism in continuous culture of mammalian cells. Biotechnol Bioeng (2000) 1.27
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
Cultivation of mammalian cells on macroporous microcarriers. Enzyme Microb Technol (1992) 1.23
Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination. J Virol (1998) 1.21
The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate. J Virol (1997) 1.16
Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol (1996) 1.14
Mouse mammary tumor virus: specific methylation patterns of proviral DNA in normal mouse tissues. J Virol (1984) 1.13
High viable cell concentration fed-batch cultures of hybridoma cells through on-line nutrient feeding. Biotechnol Bioeng (1995) 1.13
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
Micropatterning gradients and controlling surface densities of photoactivatable biomolecules on self-assembled monolayers of oligo(ethylene glycol) alkanethiolates. Chem Biol (1997) 1.11
Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg (1993) 1.11
Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell Dev Biol Anim (1996) 1.11
On-line monitoring of hybridoma cell growth using a laser turbidity sensor. Biotechnol Bioeng (1992) 1.05
Selective detection of Mycoplasma fermentans by polymerase chain reaction and by using a nucleotide sequence within the insertion sequence-like element. J Clin Microbiol (1992) 1.04
Precursor flux control through targeted chromosomal insertion of the lysine epsilon-aminotransferase (lat) gene in cephamycin C biosynthesis. J Bacteriol (1993) 1.04
The role of actin filaments and microtubules in hepatocyte spheroid self-assembly. Cell Motil Cytoskeleton (2001) 1.03
Design of retroviral vectors and helper cells for gene therapy. Pharmacol Rev (2000) 1.02
Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol (2001) 1.00
Utilization of nonhomologous minus-strand DNA transfer to generate recombinant retroviruses. J Virol (1997) 0.99
Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng (1996) 0.99
Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res (1995) 0.98
Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res (1992) 0.97
Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication. J Virol (2000) 0.97
Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. J Virol (2000) 0.97
Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine. J Virol (2000) 0.97
High density culture of mammalian cells with dynamic perfusion based on on-line oxygen uptake rate measurements. Cytotechnology (1994) 0.96
Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J Virol (1998) 0.96
Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant (1995) 0.95
Alteration of mammalian cell metabolism by dynamic nutrient feeding. Cytotechnology (1997) 0.95
Effect of glucose on the cultivation of mammalian cells. Dev Biol Stand (1987) 0.94
Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng (1993) 0.94
On-line characterization of a hybridoma cell culture process. Biotechnol Bioeng (1994) 0.94
Kinetic study of hybridoma cell growth in continuous culture. I. A model for non-producing cells. Biotechnol Bioeng (1991) 0.93
Effect of the murine leukemia virus extended packaging signal on the rates and locations of retroviral recombination. J Virol (2000) 0.93
The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA. J Virol (1999) 0.92
Probing enhanced cytochrome P450 2B1/2 activity in rat hepatocyte spheroids through confocal laser scanning microscopy. Cell Transplant (2001) 0.92
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol (1997) 0.92
The loss of antibody productivity in continuous culture of hybridoma cells. Biotechnol Bioeng (1990) 0.91
Variation of stoichiometric ratios and their correlation for monitoring and control of animal cell cultures. Biotechnol Prog (1998) 0.91
Kinetic study of hybridoma cell growth in continuous culture: II. Behavior of producers and comparison to nonproducers. Biotechnol Bioeng (1991) 0.91
A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation (1995) 0.91
Analysis of temporal and spatial expression of the CcaR regulatory element in the cephamycin C biosynthetic pathway using green fluorescent protein. Mol Microbiol (2001) 0.90
Formation of microscale gradients of protein using heterobifunctional photolinkers. Bioconjug Chem (1997) 0.90
Spatial distribution of mammalian cells grown on macroporous microcarriers with improved attachment kinetics. Biotechnol Prog (1993) 0.90
Cell volume measurement as an estimation of mammalian cell biomass. Biotechnol Bioeng (1990) 0.90
Effect of gene amplification on mercuric ion reduction activity of Escherichia coli. Appl Environ Microbiol (1991) 0.89
Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability. Biotechnol Bioeng (1993) 0.89
Fluctuations in continuous mammalian cell bioreactors with retention. Biotechnol Prog (1993) 0.89
An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology (1995) 0.89
Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant (1999) 0.88
Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel. In Vitro Cell Dev Biol Anim (1995) 0.88
Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity. J Virol (2000) 0.87
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples. Adv Virol (2011) 0.87
Determinants and rate laws of growth and death of hybridoma cells in continuous culture. Biotechnol Bioeng (1998) 0.87
Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNA. J Virol (1996) 0.87
Time-lapsed confocal microscopy reveals temporal and spatial expression of the lysine epsilon-aminotransferase gene in Streptomyces clavuligerus. Mol Microbiol (1999) 0.87
Real-time measurement of anchorage-dependent cell adhesion using a quartz crystal microbalance. Biotechnol Prog (1993) 0.86
Serial propagation of mammalian cells on gelatin-coated microcarriers. Biotechnol Bioeng (1988) 0.86
Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng (2000) 0.85
RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo. J Virol (1997) 0.85
Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J (1993) 0.84
DNA supercoiling of recombinant plasmids in mammalian cells. Proc Natl Acad Sci U S A (1986) 0.84
Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology (1992) 0.84
Identification of rate-limiting steps in cephalosporin C biosynthesis in Cephalosporium acremonium: a theoretical analysis. Appl Microbiol Biotechnol (1992) 0.83
A model for density-dependent growth of anchorage-dependent mammalian cells. Biotechnol Bioeng (1988) 0.83
Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant (1994) 0.83
Attachment and growth of mammalian cells on microcarriers with different ion exchange capacities. Biotechnol Bioeng (1987) 0.83
Confocal laser scanning microscopy examination of cell distribution in macroporous microcarriers. Biotechnol Prog (1996) 0.83
Analysis of tissue-specific methylation patterns of mouse mammary tumor virus DNA by two-dimensional Southern blotting. J Virol (1985) 0.82
Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol Bioeng (1996) 0.82
Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium. J Hematother (1995) 0.82
Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor. J Hematother (1996) 0.82
Scalable expansion of multipotent adult progenitor cells as three-dimensional cell aggregates. Biotechnol Bioeng (2011) 0.82
Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture. J Biotechnol (2010) 0.81
Alteration of cellular metabolism by consecutive fed-batch cultures of mammalian cells. J Biosci Bioeng (1999) 0.81
Production of human immune interferon by recombinant mammalian cells cultivated on microcarriers. Biotechnol Bioeng (1989) 0.81
Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). Crit Care Med (1992) 0.81
Heterogeneous distribution of lysine 6-aminotransferase during cephamycin C biosynthesis in Streptomyces clavuligerus demonstrated using green fluorescent protein as a reporter. Microbiology (2000) 0.81
Detection of prosthetic mitral valve leak: a comparative study using transesophageal echocardiography, transthoracic echocardiography, and auscultation. J Clin Ultrasound (1990) 0.80
Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription. J Virol (1999) 0.80
Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model. Transplant Proc (1993) 0.80
[Effects of neferine on platelet aggregation in rabbits]. Yao Xue Xue Bao (1997) 0.80
Long-term enhancement of cytochrome P450 2B1/2 expression in rat hepatocyte spheroids through adenovirus-mediated gene transfer. Cell Biol Toxicol (2002) 0.80
Precursor and cofactor as a check valve for cephamycin biosynthesis in Streptomyces clavuligerus. Biotechnol Prog (2000) 0.80
Population dynamics of human activated natural killer cells in culture. Biotechnol Bioeng (1994) 0.80
Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering. Metab Eng (2013) 0.79